Minimally invasive glaucoma surgery includes different devices which provide a less invasive and safer means of reducing intraocular pressure. The XEN Gel Stent (Allergan Inc., CA) is an ab interno procedure which creates a subconjunctival drainage pathway. It is a new surgical device and there is a paucity of data on complications and their management. We report a clinical case of a leaking bleb after XEN surgery managed by bleb revision, conjunctival suturing, and XEN replacement.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/IJG.0000000000000811 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!